CGGR Capital Group Growth ETF

Expense Ratio
0.39%
Dividend
0.15%
Previous close
$48.15
Est. 12 months change
+21.81%
Projected Price
$58.65

Profitability Metrics

Return on Equity (ROE)
42.08%
Return on Assets (ROA)
13.04%
Return on Invested Capital (ROIC)
29.95%
Weighted Average Cost of Capital (WACC)
11.31%
ROIC - WACC
18.64%
Updated : 2026-09-26 08:11 ET

Valuation Metrics

P/E Ratio
29.53
Forward P/E
21.42
PEG Ratio
2.09
Debt Current Ratio
2.37

Growth & Cash Flow

Gross Margin
56.35%
Operating Margin
-137.66%
FCF Margin
22.26%
TTM Revenue Growth
48.06%
Projected 12M EPS Growth
37.85%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
META7.14%
NVDA5.12%
MSFT4.73%
AVGO4.64%
TSLA4.49%
MU4.13%
GOOG3.34%
V3.28%
GOOGL3.19%
NET2.63%

ETF Analysis

Fund Overview

Capital Group Growth ETF (CGGR) currently reports 92 stock positions (subject to change), placing it in the moderately broad range by holdings breadth. The top line-up is META (7.14%), NVDA (5.12%), MSFT (4.73%), with META as the largest single weight at 7.14%. Together, the top three holdings account for 16.99%, which suggests the fund is not overly reliant on its largest positions to generate returns. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.

Profitability & Capital Efficiency

Looking at how effectively the underlying holdings deploy capital, ROIC is 29.95%, WACC is 11.31%, and the economic spread is 18.64%. On balance, returns on invested capital exceed the cost of funding by a comfortable margin, which over time compounds favorably for long-term holders. Supporting metrics show ROE at 42.08% and ROA at 13.04%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

From a pricing standpoint, the portfolio sits at trailing P/E of 29.53, forward P/E of 21.42, PEG of 2.09. The gap between trailing and forward multiples is meaningful but not wide — the market appears to be pricing a constructive but controlled earnings trajectory. The growth-adjusted multiple is neither a strong buy signal nor a clear warning — it sits in the range where execution quality will determine whether the price is ultimately justified. A current ratio reading of 2.37 points to holdings that are managing short-term obligations without apparent stress. In total, the multiple and liquidity readings describe a portfolio where valuation is a secondary risk relative to earnings delivery — the numbers are defensible if estimates hold.

Margins & Cash Generation

Across the three margin layers, gross margin sits at 56.35%, operating margin at -137.66%, and free cash flow margin at 22.26%. Gross margins sit in a healthy range, consistent with businesses that manage input costs effectively. The portfolio's operating margins are minimal, reflecting a holding set where overhead costs are not yet well absorbed by revenues. At this level, free cash flow margins suggest businesses that are building financial strength alongside revenue growth. Read together, these margin levels suggest a portfolio where earnings durability is present in parts but not consistent across the full holding set.

Growth & Forward Outlook

On a forward-looking basis, TTM revenue growth of 48.06% a signal of strong operational momentum across the holding set, while the estimated 12-month price change of 22.03%, where the target distribution indicates incremental upside rather than outsized repricing. Revenue growth and price targets are correlated but not the same — strong operations do not always translate to strong price appreciation, and vice versa. The forward return case rests on whether the businesses can sustain their operating trajectory long enough for analyst price targets to be reached or exceeded. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The full scorecard here is hard to argue with: capital efficiency is strong, margins are healthy, and growth is being priced constructively.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.